Millennium Laboratories has entered into a national agreement with Aetna for providing patient monitoring services.
Under the terms of the three-year ancillary services agreement Millennium will assist Aetna participating physicians nationwide with therapeutic drug monitoring devices and services. These will help physicians better manage their patients’ pain while at the same time aiding compliance with pain medication regimens.
James Slattery, CEO of Millennium Laboratories, said: “We are proud to have been selected by Aetna as a national pain management services provider. Aetna’s support of therapeutic drug monitoring services for their participating physicians advances urine drug screening as a standard of care to ensure patients have quality pain management.
“As a leader in this field, pain physicians know they can rely on Millennium Laboratories as we provide the fastest turn-around time in the industry for drug test reporting and final confirmation of results because we exclusively utilize the latest cutting-edge technology, Liquid Chromatography/Mass Spectrometry/Mass Spectrometry (LC-MS/MS).”